Chang M, Peng C, Chen C, Shih Y, Chen J, Tai Y
Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770405
PMC: 11676292.
DOI: 10.3390/ph17121563.
Klimek K, Groener D, Chen X, Rowe S, Speer T, Higuchi T
Theranostics. 2024; 14(18):7111-7121.
PMID: 39629123
PMC: 11610144.
DOI: 10.7150/thno.102552.
Jimenez C, Baudrand R, Uslar T, Bulzico D
Ther Adv Med Oncol. 2024; 16:17588359241301359.
PMID: 39574494
PMC: 11580098.
DOI: 10.1177/17588359241301359.
Hoogenkamp D, de Wit-van der Veen L, Huizing D, Tesselaar M, van Leeuwaarde R, Stokkel M
Curr Oncol Rep. 2024; 26(5):551-561.
PMID: 38598035
PMC: 11062977.
DOI: 10.1007/s11912-024-01521-w.
Moraitis A, Jentzen W, Reiter G, Schmitz J, Poppel T, Weber M
EJNMMI Phys. 2024; 11(1):3.
PMID: 38167953
PMC: 10761661.
DOI: 10.1186/s40658-023-00604-0.
Validation of a Five-Year Prognostic Model Using I-metaiodobenzylguanidine Scintigraphy in Patients with Heart Failure.
Ishibashi Y, Kasama S, Kurabayashi M, Ishii H
Ann Nucl Cardiol. 2023; 9(1):40-47.
PMID: 38058571
PMC: 10696150.
DOI: 10.17996/anc.23-00177.
Hybrid Molecules of Benzylguanidine and the Alkylating Group of Melphalan: Synthesis and Effects on Neuroblastoma Cells.
Bruchelt G, Klose C, Lischka M, Brandes M, Handgretinger R, Brueckner R
J Clin Med. 2023; 12(13).
PMID: 37445504
PMC: 10342853.
DOI: 10.3390/jcm12134469.
Early Effect of Transcatheter Mitral Valve Repair on Cardiac Sympathetic Nerve Activity.
Yokoyama H, Shishido K, Mizuno S, Yamanaka F, Saito S
Struct Heart. 2023; 7(3):100153.
PMID: 37273854
PMC: 10236802.
DOI: 10.1016/j.shj.2022.100153.
Synthesis of Radioiodinated Compounds. Classical Approaches and Achievements of Recent Years.
Petrov S, Yusubov M, Beloglazkina E, Nenajdenko V
Int J Mol Sci. 2022; 23(22).
PMID: 36430267
PMC: 9698107.
DOI: 10.3390/ijms232213789.
Reporter Transgenes for Monitoring the Antitumor Efficacy of Recombinant Oncolytic Viruses.
Semenova A, Sivolobova G, Grazhdantseva A, Agafonov A, Kochneva G
Acta Naturae. 2022; 14(3):46-56.
PMID: 36348722
PMC: 9611865.
DOI: 10.32607/actanaturae.11719.
Neuroblastoma: When differentiation goes awry.
Zeineldin M, Patel A, Dyer M
Neuron. 2022; 110(18):2916-2928.
PMID: 35985323
PMC: 9509448.
DOI: 10.1016/j.neuron.2022.07.012.
Reclassification of Heart Failure with Preserved Ejection Fraction Following Cardiac Sympathetic Nervous System Activation: A New Cutoff Value of 58.
Goto T, Nakayama T, Yamamoto J, Mori K, Shintani Y, Kikuchi S
Tomography. 2022; 8(3):1595-1607.
PMID: 35736880
PMC: 9229723.
DOI: 10.3390/tomography8030132.
.
Quinones A, Vieira L, Wang J
Drug Metab Dispos. 2022; 50(9).
PMID: 35197314
PMC: 9488973.
DOI: 10.1124/dmd.121.000707.
Biological Distribution of Orally Administered [I]MIBG for Estimating Gastrointestinal Tract Absorption.
Kobayashi M, Mizutani A, Muranaka Y, Nishi K, Komori H, Nishii R
Pharmaceutics. 2022; 14(1).
PMID: 35056957
PMC: 8779057.
DOI: 10.3390/pharmaceutics14010061.
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma.
Inaki A, Shiga T, Tsushima Y, Jinguji M, Wakabayashi H, Kayano D
Ann Nucl Med. 2021; 36(3):267-278.
PMID: 34870794
PMC: 8897386.
DOI: 10.1007/s12149-021-01699-0.
Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma.
Carrasquillo J, Chen C, Jha A, Pacak K, Pryma D, Lin F
J Nucl Med. 2021; 62(9):1192-1199.
PMID: 34475242
PMC: 8882896.
DOI: 10.2967/jnumed.120.259697.
Evaluation of Iodine-123 and Iodine-131 SPECT activity quantification: a Monte Carlo study.
Morphis M, van Staden J, du Raan H, Ljungberg M
EJNMMI Phys. 2021; 8(1):61.
PMID: 34410539
PMC: 8377107.
DOI: 10.1186/s40658-021-00407-1.
Imaging of Pheochromocytoma and Paraganglioma.
Carrasquillo J, Chen C, Jha A, Ling A, Lin F, Pryma D
J Nucl Med. 2021; 62(8):1033-1042.
PMID: 34330739
PMC: 8833868.
DOI: 10.2967/jnumed.120.259689.
Effects of mineralocorticoid receptor antagonist eplerenone on cardiac sympathetic nerve activity and left ventricular remodeling after reperfusion therapy in patients with first ST-segment elevation myocardial infarction.
Toda K, Kasama S, Toyama T, Kasahara M, Kurabayashi M
J Nucl Cardiol. 2021; 29(5):2325-2335.
PMID: 34272676
DOI: 10.1007/s12350-021-02733-4.
High-specific-activity iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma.
Dillon J, Bushnell D, Laux D
Future Oncol. 2021; 17(10):1131-1141.
PMID: 33506713
PMC: 7927907.
DOI: 10.2217/fon-2020-0625.